PainReform Ltd- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 PainReform Ltd 公司

PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

PainReform Ltd简介



公司代码PRFX

公司名称PainReform Ltd

上市日期Sep 01, 2020

CEOHadar (Ilan)

员工数量2

证券类型Ordinary Share

年结日Sep 01

公司地址65 Yigal Alon St.

城市TEL AVIV-YAFO

上市交易所NASDAQ OMX - NASDAQ BASIC

国家Israel

邮编6744316

电话97237177051

网址https://painreform.com/

公司代码PRFX

上市日期Sep 01, 2020

CEOHadar (Ilan)

PainReform Ltd公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Ilan Hadar

Chief Executive Officer, Chief Financial Officer

--

Dr. Eli Hazum

Chief Technology Officer, Director

--

Dr. Sigal Aviel

Chief Operating Officer

--

Mrs. Rita Keynan

Vice President - Pharmaceutical Operations

--

Dr. Ehud Geller, Ph.D.

Chairman of the Board

--

Mr. Efi Cohen-Arazi

Independent Director

--

Dr. Ellen S. Baron

Independent Director

--

Mr. Augustine J. (Gus) Lawlor

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Ilan Hadar

Chief Executive Officer, Chief Financial Officer

--

Dr. Eli Hazum

Chief Technology Officer, Director

--

Dr. Sigal Aviel

Chief Operating Officer

--

Mrs. Rita Keynan

Vice President - Pharmaceutical Operations

--

Dr. Ehud Geller, Ph.D.

Chairman of the Board

--

Mr. Efi Cohen-Arazi

Independent Director

--

收入明细

由于公司未披露，未能获取相关数据

由于公司未披露，未能获取相关数据

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月17日周一

持股股东

股东类型

持股股东

占比

Bladeranger Ltd

4.57%

Two Sigma Investments, LP

0.41%

Medica Venture Partners

0.35%

L.I.A. Pure Capital Ltd

0.27%

UBS Financial Services, Inc.

0.11%

其他

94.29%

持股股东

占比

Bladeranger Ltd

4.57%

Two Sigma Investments, LP

0.41%

Medica Venture Partners

0.35%

L.I.A. Pure Capital Ltd

0.27%

UBS Financial Services, Inc.

0.11%

其他

94.29%

股东类型

持股股东

占比

Corporation

4.83%

Hedge Fund

0.41%

Private Equity

0.35%

Investment Advisor

0.12%

其他

94.29%

机构持股



更新时间: 1月1日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q4

15

6.89K

0.88%

-9.63K

2025Q3

15

20.01K

0.99%

-66.86K

2025Q2

22

221.75K

11.02%

-42.46K

2025Q1

21

208.02K

26.50%

+122.57K

2024Q4

19

72.04K

4.22%

+19.22K

2024Q3

16

43.23K

4.31%

+4.77K

2024Q2

16

35.44K

14.31%

+7.32K

2024Q1

15

25.67K

11.49%

-2.27K

2023Q4

17

26.00K

30.19%

+5.33K

2023Q3

18

17.50K

39.02%

-5.90K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Bladeranger Ltd

178.77K

4.57%

--

Apr 01, 2025

Two Sigma Investments, LP

16.19K

0.41%

+16.19K

--

Sep 30, 2025

Medica Venture Partners

13.72K

0.35%

+2.00

+0.01%

Apr 01, 2025

L.I.A. Pure Capital Ltd

10.42K

0.27%

+10.42K

--

Aug 28, 2024

UBS Financial Services, Inc.

19.00

0%

-6.07K

-99.69%

Sep 30, 2025

Osaic Holdings, Inc.

193.00

0%

--

Sep 30, 2025

SBI Securities Co., Ltd.

6.00

0%

--

Sep 30, 2025

Virtu Americas LLC

--

0%

-836.00

-100.00%

Sep 30, 2024

Geode Capital Management, L.L.C.

--

0%

-80.00

-100.00%

Oct 31, 2024

Citadel Advisors LLC

--

0%

-715.00

-100.00%

Jun 30, 2024

持股ETF



机构名称

占比

暂无数据

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

Feb 03, 2026

Merger

5→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Sep 05, 2024

Merger

6→1

公告日期

除权除息日

类型

比率

Feb 03, 2026

Merger

5→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Sep 05, 2024

Merger

6→1

Sep 05, 2024

Merger

6→1

Sep 05, 2024

Merger

6→1

Sep 05, 2024

Merger

6→1

Jun 30, 2023

Merger

10→1